GDRX
insider transactionsGoodRx Holdings, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 30d
No open-market buys or sells in this period — showing all activity (grants, exercises & gifts).
-
Grant·A
Director
$0
73.4K sh
Own +21%
-
Grant·A
Director
$0
73.4K sh
Own +30%
-
Grant·A
Director
$0
73.4K sh
Own +34%
-
Grant·A
Director
$0
73.4K sh
Own +55%
-
Grant·A
Director
$0
73.4K sh
Own +55%
-
Grant·A
Director
$0
73.4K sh
Own +27%
-
Exercise·M
Chief Accounting Officer
$0
4.1K sh · 2 lots
Own +38%
-
Other·F
Chief Accounting Officer
$5.5K
2.1K sh · $2.65 avg · 2 lots
Own -27%
-
Exercise·M
Chief Accounting Officer
—
4.1K sh · 2 lots
Own +149%
-
Grant·A
Director
$0
110.3K sh
Own +69%
-
Grant·A
Director
$0
4.6K sh
Own +2%
-
Grant·A
Director
$0
4.6K sh
Own +4%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | REY-GIRAUD AGNES | Grant A | 73.4K | $0 |
| Jun 16, 2026 | Hirsch Douglas Joseph | Grant A | 73.4K | $0 |
| Jun 16, 2026 | Wagner Scott | Grant A | 73.4K | $0 |
| Jun 16, 2026 | Kennedy Kelly J. | Grant A | 73.4K | $0 |
| Jun 16, 2026 | Bruehlman Ronald E | Grant A | 73.4K | $0 |
| Jun 16, 2026 | Bezdek Trevor | Grant A | 73.4K | $0 |
| Jun 15, 2026 | Thomas (Tc) Chan | Exercise M | 4.1K2 lots | $0 |
| Jun 15, 2026 | Thomas (Tc) Chan | Other F | 2.1K2 lots | $5.5K |
| Jun 15, 2026 | Thomas (Tc) Chan | Exercise M | 4.1K2 lots | — |
| Jun 8, 2026 | Bezdek Trevor | Grant A | 110.3K | $0 |
| May 27, 2026 | Hirsch Douglas Joseph | Grant A | 4.6K | $0 |
| May 27, 2026 | Bruehlman Ronald E | Grant A | 4.6K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About GDRX insider trading
This page tracks insider transactions for GoodRx Holdings, Inc. (GDRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.